Lista de obras - M Ilié - Dominio Público Uruguay

"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

artículo científico publicado en 2019

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease

artículo científico publicado en 2014

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

artículo científico publicado en 2018

Accréditation de l’activité de pathologie moléculaire selon la norme ISO 15189. Principales étapes à respecter et principaux écueils possibles

artículo científico publicado en 2013

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

scientific article published in 2023

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

artículo científico publicado en 2018

Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

scientific article published on 18 October 2019

Atezolizumab in advanced non-small cell lung cancer.

artículo científico publicado en 2017

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer

scientific article published on 31 July 2018

Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

artículo científico publicado en 2013

BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.

artículo científico publicado en 2014

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

artículo científico publicado en 2011

Caractéristiques morphologiques et principales étiologies des infections rhino-sinusiennes

scientific article published on 16 September 2009

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

artículo científico publicado en 2019

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France

artículo científico publicado en 2017

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.

artículo científico publicado en 2014

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

scientific article published on 19 October 2015

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

scientific article published on 01 July 2019

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

artículo científico publicado en 2017

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

artículo científico publicado en 2011

Dermoscopy of eccrine angiomatous hamartoma: The spitzoid pattern

scientific article published on 18 September 2018

Detection and characterization of circulating tumor cells in lung cancer: Why and how?

artículo científico publicado en 2015

Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer

artículo científico publicado en 2018

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

artículo científico publicado en 2011

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls

artículo científico

Diagnostic Value of Immunohistochemistry for the Detection of the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays

article

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients.

artículo científico publicado en 2012

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

artículo científico publicado en 2014

Disseminated infection caused by Sparganum proliferum in an AIDS patient

artículo científico publicado en 2010

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.

artículo científico publicado en 2009

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients

article

Enjeux et limites actuelles de l’évaluation du statut de PD-L1 par immunohistochimie sur des biopsies bronchiques

artículo científico publicado en 2016

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

artículo científico publicado en 2018

Erratum à l’article : « Immunohistochimie PD-1/PD-L1 en oncologie thoracique : où en sommes-nous ? » [Ann. Pathol. 37(1) (2017) 39–45]

scientific article published on 01 August 2017

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

artículo científico publicado en 2018

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients

artículo científico publicado en 2017

Fibronectin-guided migration of carcinoma collectives

artículo científico publicado en 2017

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

artículo científico publicado en 2015

Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer

article

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness

artículo científico publicado en 2016

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.

artículo científico publicado en 2018

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma ⬇️

artículo científico publicado el 18 de noviembre de 2011

Immunotherapy supplanting chemotherapy for upfront treatment of advanced non-small cell lung cancer: what's next?

artículo científico publicado en 2017

KRAS and bronchial adenocarcinoma. Between disappointments and hopes

artículo científico publicado en 2015

LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

artículo científico publicado en 2009

L’accréditation selon la norme ISO 15189 d’un laboratoire de pathologie et de génétique somatique (LPCE, CHU de Nice) : retour d’expérience

artículo científico publicado en 2013

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells

scientific article published on 19 July 2018

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.

artículo científico publicado en 2016

Mise en place d’indicateurs de suivi au sein d’une tumorothèque et/ou d’un centre de ressources biologiques : pourquoi et comment ?

artículo científico publicado en 2012

Mise en place d’un secteur de pathologie moléculaire en oncologie au sein d’un laboratoire d’anatomie pathologique (LPCE, CHU de Nice)

scientific article published on 30 January 2013

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

artículo científico publicado en 2018

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

artículo científico publicado en 2019

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

artículo científico publicado en 2022

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

artículo científico publicado en 2017

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.

artículo científico publicado en 2017

Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis

artículo científico publicado en 2010

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1(+) and CD8(+) tumor-infiltrating T cells and outcome.

artículo científico publicado en 2016

Pericardial effusion as primary manifestation of metastatic cutaneous adenoid cystic carcinoma: diagnostic cytopathology from an exfoliative sample

scientific article published on 01 May 2008

Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer

scientific article published on 25 August 2011

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

artículo científico publicado en 2018

Pros: Can tissue biopsy be replaced by liquid biopsy?

artículo científico publicado en 2016

Que reste t-il de la microscopie électronique pour le diagnostic anatomopathologique en 2010 ?

scientific article published on 31 July 2010

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.

artículo científico publicado en 2016

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.

artículo científico publicado en 2018

Rebuttal from Dr. Hofman and Dr. Ilié.

artículo científico publicado en 2016

Reply to the letter to the editor 'ALK FISH rearranged and amplified tumor with negative immunohistochemistry: a rare and challenging case concerning ALK status screening in lung cancer' by Uguen et al.

artículo científico publicado en 2015

Reproducibility of PD-L1 assessment in non-small cell lung cancer-know your limits but never stop trying to exceed them.

artículo científico publicado en 2017

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer

artículo científico publicado en 2017

Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps

artículo científico publicado en 2014

Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma.

artículo científico publicado en 2013

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.

artículo científico publicado en 2018

Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma

scientific article published on 01 December 2018

Standard of care of carcinomas on cancer of unknown primary site in 2016

artículo científico publicado en 2016

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

artículo científico publicado en 2015

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

scientific article published on 13 April 2020

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again

scientific article published on 21 February 2019

The biological rationale for immunotherapy in cancer

artículo científico publicado en 2018

The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress

scientific article published on 15 August 2019

Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes.

artículo científico publicado en 2014

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.

artículo científico publicado en 2018

Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

artículo científico publicado en 2017

Use of the 22C3 anti-programmed death ligand 1 antibody to determine programmed death ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients.

artículo científico publicado en 2018

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients.

artículo científico publicado en 2018

Usefulness of ancillary methods for diagnosis, prognosis and targeted therapy in thyroid pathology.

artículo científico

Usefulness of oral cytopathology in the diagnosis of infectious diseases.

artículo científico publicado en 2010

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.

artículo científico publicado en 2010

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

artículo científico publicado en 2018

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France).

artículo científico publicado en 2015

[Carcinoma of unknown primary. Case no. 7]

artículo científico publicado en 2018

[Carcinoma of unknown primary. Role of the pathologist in 2018: Introduction]

artículo científico publicado en 2018

[Immunohistochemistry and personalised medicine in lung oncology: advantages and limitations]

artículo científico publicado en 2014

[PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?]

scientific article published on 31 January 2017

[Role of the surgical pathologist for tissue management in oncology]

artículo científico publicado en 2013

p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.

artículo científico publicado en 2016

Lista de obras de M Ilié

"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

Accréditation de l’activité de pathologie moléculaire selon la norme ISO 15189. Principales étapes à respecter et principaux écueils possibles

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Association of combined PD-L1 expression and tumour-infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

Atezolizumab in advanced non-small cell lung cancer.

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer

Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

Caractéristiques morphologiques et principales étiologies des infections rhino-sinusiennes

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

Dermoscopy of eccrine angiomatous hamartoma: The spitzoid pattern

Detection and characterization of circulating tumor cells in lung cancer: Why and how?

Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls

Diagnostic Value of Immunohistochemistry for the Detection of the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients.

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

Disseminated infection caused by Sparganum proliferum in an AIDS patient

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients

Enjeux et limites actuelles de l’évaluation du statut de PD-L1 par immunohistochimie sur des biopsies bronchiques

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA.

Erratum à l’article : « Immunohistochimie PD-1/PD-L1 en oncologie thoracique : où en sommes-nous ? » [Ann. Pathol. 37(1) (2017) 39–45]

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients

Fibronectin-guided migration of carcinoma collectives

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site.

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma ⬇️

Immunotherapy supplanting chemotherapy for upfront treatment of advanced non-small cell lung cancer: what's next?

KRAS and bronchial adenocarcinoma. Between disappointments and hopes

LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

L’accréditation selon la norme ISO 15189 d’un laboratoire de pathologie et de génétique somatique (LPCE, CHU de Nice) : retour d’expérience

Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib.

Mise en place d’indicateurs de suivi au sein d’une tumorothèque et/ou d’un centre de ressources biologiques : pourquoi et comment ?

Mise en place d’un secteur de pathologie moléculaire en oncologie au sein d’un laboratoire d’anatomie pathologique (LPCE, CHU de Nice)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Mutations in <i>KMT2C</i>, <i>BCOR</i> and <i>KDM5C</i> Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer.

Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1(+) and CD8(+) tumor-infiltrating T cells and outcome.

Pericardial effusion as primary manifestation of metastatic cutaneous adenoid cystic carcinoma: diagnostic cytopathology from an exfoliative sample

Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy

Pros: Can tissue biopsy be replaced by liquid biopsy?

Que reste t-il de la microscopie électronique pour le diagnostic anatomopathologique en 2010 ?

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.

Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.

Rebuttal from Dr. Hofman and Dr. Ilié.

Reply to the letter to the editor 'ALK FISH rearranged and amplified tumor with negative immunohistochemistry: a rare and challenging case concerning ALK status screening in lung cancer' by Uguen et al.

Reproducibility of PD-L1 assessment in non-small cell lung cancer-know your limits but never stop trying to exceed them.

Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer

Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps

Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma.

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.

Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma

Standard of care of carcinomas on cancer of unknown primary site in 2016

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again

The biological rationale for immunotherapy in cancer

The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress